旅行疫苗市场基于(主要地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00007439
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 198
Buy Now

旅行疫苗市场预计将从 2021 年的 30.7894 亿美元增至 2028 年的 59.1422 亿美元。预计 2021 年至 2028 年复合年增长率为 9.8%。

旅行疫苗,也称为旅行免疫接种,是旅行者在前往世界某些地区之前可以接种的疫苗,有助于保护他们免受旅行者前往地区常见的严重感染和疾病的侵害。旅行疫苗是保护旅行者免于将可能导致地方病或疫情爆发的感染带回家的安全有效的方法。它们的目的是保护旅行者并防止国家内部和国家之间的疾病爆发。有些国家甚至要求往返某个国家的旅行者提供疫苗接种证明。旅游业的快速增长和传染病发病率的上升促进了市场的进步。然而,旅行疫苗的高成本阻碍了旅行疫苗市场的增长。

旅行疫苗市场是根据产品、应用和地理位置进行评估的。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美和非洲中美洲。旅行疫苗市场报告提供了对市场的见解和深入分析,强调旅行疫苗市场规模、市场趋势、技术进步和市场动态等参数,以及对领先市场参与者的竞争格局的分析。< /p>

战略洞察

由于旅行和旅游的增加、跨国感染的预防以及旅游疫苗市场规模的增长,预计旅行疫苗市场规模将会增长。传染病发病率不断上升。然而,旅行疫苗的高成本预计将阻碍旅行疫苗市场的增长。

旅行疫苗市场的利润丰厚区域

< br />

市场洞察

增加旅行和旅游旅游带动旅游疫苗市场

随着出行旅游成为人类生活方式的重要组成部分,旅游旅游业蓬勃发展。旅行和旅游不仅改变了人们的日常生活,而且还提供了探索不同文化、传统、唯灵论和医疗旅游的机会。根据 Skyscanner 的千禧一代旅行研究进行的一项调查,超过约 1,000 名千禧一代(18-35 岁)接受了有关他们的首选目的地、旅行方式和兴趣等因素的调查,调查显示,大部分人与国内目的地相比,受访者更喜欢前往国际目的地。调查还指出,欧洲目的地以及美国和新西兰都是所有年龄段游客的最爱。此外,从世界旅游组织收集数据的《Our World in Data》统计数据显示,2019年各个地区的旅游业都有所增长,例如欧盟的入境人数约为9.6644亿人次,北美的入境人数约为2亿人次,中东和非洲的入境人数约为2亿人次。 ;北非约有 128 人抵达。此外,2018 年法国入境人数为 2.12 亿人次,而西班牙等其他欧洲国家 2019 年入境人数为 1.2617 亿人次。

联合国世界旅游组织 (UNWTO)数据显示,入境人数不断增加,2019年入境人数为24.03亿人次,国际旅游支出估计为14.39亿美元。虽然 COVID-19 大流行极大地扰乱了这一趋势,但抗 COVID-19 疫苗接种推动了大众的推广,加上 COVID-19 安全旅行法规预计将有助于旅游业和旅行的正常化。在旅行期间,旅行者面临感染区域疾病的风险,这可能导致跨国疾病暴发/流行。因此,出国旅行需要免疫接种作为安全和预防措施,以避免此类感染的传播。各个国家都有自己的授权和法规来保护其公民免受旅行相关感染。例如,英国的国家医疗服务体系(NHS)为其公民组织常规免疫或疫苗接种计划。如果一个人在英国境外旅行,他/她需要接种疫苗以预防甲型肝炎、伤寒和黄热病等传染病。同样,在沙特阿拉伯,来自朝觐和副朝朝圣的旅客必须出示脑膜炎和季节性流感疫苗接种证明。许多国家/地区要求在国际疫苗接种或预防证书 (ICVP) 上记录强制性疫苗接种证明。需要针对美国 HHS(卫生与公众服务部)提到的疾病进行疫苗接种,例如水痘、霍乱、COVID-19、白喉、流感、甲型肝炎、乙型肝炎、流感嗜血杆菌型B、人乳头瘤病毒、日本脑炎、麻疹、脑膜炎球菌、腮腺炎、肺炎球菌、脊髓灰质炎、狂犬病、轮状病毒、风疹、带状疱疹、破伤风、伤寒、百日咳和黄热病,具体取决于旅行国家/地区。对区域疾病在各国传播的担忧正在推动旅行疫苗市场的需求。

基于产品的见解

基于产品,全球旅行疫苗市场分为甲型肝炎、乙型肝炎、脑膜炎球菌疫苗、百白破、黄热病、伤寒、日本脑炎、麻疹腮腺炎和流感疫苗。风疹、狂犬病、脊髓灰质炎、流感、水痘和水痘带状疱疹、霍乱等。甲型肝炎细分市场在 2021 年占据最大的旅行疫苗市场份额。虽然甲型肝炎细分市场预计将在预测期内占据最大份额,但 DPT 细分市场预计在预测期间将在旅行疫苗市场中实现最高的复合年增长率由于旅行前 DPT 疫苗的使用量增加。预计这将有助于在旅行前使用百白破疫苗,并进一步推动未来几年旅行疫苗市场的增长。

旅行疫苗市场(按产品) - 2021年和2028年

基于应用的洞察

根据应用,市场分为国内游和出境游旅行。出境游细分市场在 2021 年占据了更大的市场份额,预计在预测期内市场复合年增长率将更高。商务、旅游和其他目的(例如医疗旅游和移民)旅行的增加正在促进全球出境旅行,从而推动对旅行疫苗的需求。

 

公司通常采用有机战略来扩大其在市场上的足迹和产品组合。此外,这些公司还实施了各种无机战略,例如并购和合作伙伴关系。例如,2021 年 2 月,Dynavax Technologies Corporation 宣布欧盟委员会 (EC) 授予 HEPLISAV B [乙型肝炎疫苗(重组),佐剂] 的营销授权,用于针对所有已知引起的乙型肝炎病毒感染 (HBV) 进行主动免疫。 18 岁及以上成年人的乙型肝炎病毒亚型。该批准是在欧洲药品管理局 (EMA) 对公司的营销授权申请给予有利意见后发布的。

公司简介

  • 葛兰素史克公司
  • 默克公司有限公司
  • 赛诺菲
  • 诺华公司
  • 辉瑞公司
  • Dynavax Technologies
  • Emergent BioSolutions Inc.
  • 雅培
  • Bharat Biotech
  • Valneva SE
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the Travel Vaccines Market?

The travel vaccines market majorly consists of the players such as GlaxoSmithKline plc; Merck & Co., Inc; Sanofi; Novartis AG; Pfizer Inc; Dynavax Technologies; Emergent BioSolutions Inc; Abbott; Bharat Biotech, and Valneva SE among others.

Which segment is dominating the Travel Vaccines Market?

The travel vaccines market is analyzed in the basis of product and application. Based on product, is segmented into hepatitis A, hepatitis B, meningococcal infections, diphtheria pertussis tetanus (DPT), yellow fever typhoid, Japanese encephalitis, measles mumps & rubella, rabies, polio, influenza, varicella & shingles, cholera, and others. Among the product, the hepatitis A segment was dominating the market in 2021. And based on the application, outbound travel held the largest market for the market and is expected to continue its dominance in the coming future.

What are the driving factors for the global travel vaccines market across the country?

The factors that are driving the growth of the market are increasing travel and tourism, prevention of transnational infections, and growing incidences of infectious diseases. However, the high cost of travel vaccines is likely to hinder the market’s growth.

What are the travel vaccines?

Travel vaccines, also called travel immunizations, are shots travelers can get before visiting certain areas of the world that help protect them from serious illnesses. Vaccinations work by exposing the body to germs or parts of germs of the disease it will protect against. Travel vaccines are safe, effective ways to help protect travelers from bringing home more than they bargained for. These vaccines are recommended to provide protection against diseases endemic to the country of origin or of destination. They are intended to protect travelers and to prevent disease spread within and between countries. Some countries require proof of vaccination for travelers wishing to enter or exit the country.

The List of Companies - Travel Vaccines Market

  1. GlaxoSmithKline plc
  2. Merck & Co., Inc.
  3. Sanofi
  4. Novartis AG
  5. Pfizer Inc.
  6. Dynavax Technologies
  7. Emergent BioSolutions Inc.
  8. Abbott
  9. Bharat Biotech
  10. Valneva SE.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports